Melissa Lowman, APRN
Family · Russellville, ARNPI 1235837279
Payments from drug & device makers
Across 20 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$82
- Novartis$81
- Amgen$81
- Scpharmaceuticals Inc.$47
- Bayer$31
- Vifor Pharma, Inc.$24
- plus $46 from 3 others
What the payments were for
- Food & beverage$391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 3 | $82 |
| Novartis | 4 | $81 |
| Amgen | 4 | $81 |
| Scpharmaceuticals Inc. | 3 | $47 |
| Bayer | 2 | $31 |
| Vifor Pharma, Inc. | 1 | $24 |
| AstraZeneca | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Akebia Therapeutics Inc | 1 | $15 |
How this compares
$391 in reported general payments places this provider in the 50th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 129 | $1,316 |
| Azelastine Hcl | 33 | $700 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $644 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 11 | $618 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 35 | $448 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 46 | $436 |
| Oseltamivir Phosphate | 11 | $375 |
| Ondansetron OdtOndansetron | 43 | $354 |
| Azithromycin | 66 | $293 |
| Cephalexin | 11 | $289 |
| Doxycycline Hyclate | 19 | $268 |
| Amoxicillin | 41 | $168 |
| Cyclobenzaprine Hcl | 22 | $97 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $96 |
| Mupirocin | 17 | $94 |
Paid to pharmacies, not to this prescriber.
Other family in Russellville
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.